ADVISORY/MDS Proteomics SVP of Discovery Research Michael Moran to Present ``Targeting Intervention Points Through Protein Pathways'' at BioFuture 2001.News/Assignment Editors ADVISORY...for Thursday (Sep. 6) --(BUSINESS WIRE)
WHO: MDS Proteomics SVP of Discovery Research Michael Moran
WHAT: During his presentation, Moran will discuss how MDS
Proteomics gains insight into protein functions at the
cellular level to yield high quality targets for designing
new medicines.
WHY: MDS Proteomics has developed exceptional capabilities in
proteomics systems, technology, supercomputing, drug
screening and biology and is uniquely positioned to build
an effective bridge between gene discovery and therapeutic
development.
WHERE: BioFuture 2001
Metro Toronto Convention Centre
255 Front Street West
Toronto, Ontario
WHEN: Thursday, Sept. 6, 2001, 9:15 a.m. EDT
A pioneer in the field of proteomic-enabled drug discovery, MDS MDS, n See temporomandibular pain-dysfunction syndrome. MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there Proteomics pro·te·o·mics n. The analysis of the expression, localization, functions, and interactions of the proteins produced by the genes of an organism. mission is to significantly improve the productivity of the pharmaceutical industry in discovering and developing new medicines for the treatment of disease. The company has formed strategic partnerships with leading pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , including IBM (International Business Machines Corporation, Armonk, NY, www.ibm.com) The world's largest computer company. IBM's product lines include the S/390 mainframes (zSeries), AS/400 midrange business systems (iSeries), RS/6000 workstations and servers (pSeries), Intel-based servers (xSeries) , Abgenix, Agilent, Partners Healthcare Partners HealthCare is a non-profit organization that owns several hospitals in Massachusetts, primarily in the Boston area. Massachusetts General Hospital and Brigham and Women's Hospital founded the organization in 1994. and Zyomyx to target human anti-body candidates for further development of, and eventual treatment of, a wide range of specific diseases. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion